Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs

Weisbach L, Schuster AK, Hartmann M, Dürr P, Then M, Andrikyan W, Fromm M, Maas R, Farker K (2023)


Publication Type: Journal article, Original article

Publication year: 2023

Journal

Book Volume: 89

Pages Range: 2552-2560

Journal Issue: 8

DOI: 10.1111/bcp.15730

Abstract

Aims: Prescribing information should follow a defined structure to help prescribers easily find required information. Often information appears in different sections of Summaries of Product Characteristics (SmPCs) in an inconsistent way. Still unknown is how this inconsistency affects absolute contraindications and how it can be improved. Thisstudy aimed to evaluate the structure of absolute contraindications in SmPCs based on absolute drug-drug contraindications (DDCI) in the section 'contraindications' and references to sections 'special warnings and precautions for use' (here as 'warnings') and 'interaction with other medicinal products and other forms of interaction' (here as 'interactions').

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Weisbach, L., Schuster, A.K., Hartmann, M., Dürr, P., Then, M., Andrikyan, W.,... Farker, K. (2023). Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs. British Journal of Clinical Pharmacology, 89(8), 2552-2560. https://dx.doi.org/10.1111/bcp.15730

MLA:

Weisbach, Laura, et al. "Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs." British Journal of Clinical Pharmacology 89.8 (2023): 2552-2560.

BibTeX: Download